News & Articles

Highly complementary technologies strengthen Thermo Fisher’s portfolio in bioprocessing and adjacent markets

Accelerated platform delivers validated biomarkers with ready-to-use Optimer ligands in months rather than years

CAL101 is a first-in-class monoclonal antibody that neutralises the S100A4 protein, which is an upstream driver and amplifier of the multiple pro-fibrotic pathways active in IPF

Learn how Inotiv’s proteomics services are helping researchers gain deeper insights into drug target systems, to better select disease models, and quantify pathology data

The initiative aims to identify and support new ideas for innovative oral formulations for peptide drugs such as GLP-1 receptor agonists

As part of our aim to improve our service to scientists and laboratory professionals, we invite you to complete the SelectScience 2025 survey

As the FDA and NIH plan to phase out animal-based drug testing, organ-chip models are filling this critical gap

Dr. Michael Kiebish of BPGbio shares insight into its AI-powered NAi Interrogative Biology Platform and discusses the growing importance of multiomic data

The comprehensive preclinical screening platform was validated using HER2 x TROP2 bsADC as a proof of concept

To help simulate exact environmental conditions for shipping, storage, or research environments, offering repeatable and consistent performance

Designed to support drug developers in bringing their therapeutics to market faster, more efficiently, and with greater reliability

With smarter tools, AI-powered insights, and a focus on user experience, lab automation is becoming more accessible, flexible, and impactful than ever

With intuitive workflows, quick setup, and expert support, Veya is making automation accessible and cost-effective for first-time users

This guest editorial outlines how the collaboration between Camena Bioscience and SPT Labtech is driving innovation in the field of DNA synthesis

Guest editorial features key takeaways from Balancing the Future Podcast, by METTLER TOLEDO

Experienced clinical immunologist and global life science executive to support progression of lead candidate through the clinic

New UK-based technical innovation facility opens in Nuneaton on MIRA Tech Park

A nasal vaccine could prove both more effective medically and more tolerable for young children and adults who may fear needles

New workflow streamlines protein structural analysis and supports the growing role of AI in drug discovery

Breakthrough demonstrates the potential of 3D multi-omics to revolutionize drug discovery timelines and success rates across various disease area

Advance gene therapy precision by reliably testing pre-existing AAV immunogenicity

A renewed image for a company in constant evolution, driven by curiosity

Strategic collaboration to innovate Treg and TIL therapies, streamline cell therapy workflows, and enhance manufacturing efficiency